INOCA: Evaluación no invasiva de los mecanismos fisiopatológicos mediante CZT-SPECT
GOBBO, MAGALI Y.; MERETTA, ALEJANDRO H.; SCIANCALEPORE, MARÍA; RETAMOZO, ERICA; BEBER, ESTEFANIA; ROSA, DANIEL; PÉREZ BALIÑO, NÉSTOR A.; MASOLI, OSVALDO H..
Rev. argent. cardiol
; 90(3): 194-202, ago. 2022. tab, graf
Artículo en Español |
LILACS-Express
| ID: biblio-1407143
Documentos relacionados
Integration of quantitative absolute myocardial blood flow estimates from dynamic CZT-SPECT improves the detection of coronary artery disease.
Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.
Coronary microvascular dysfunction affects left ventricular global longitudinal strain response to dipyridamole stress echocardiography: a pilot study.
[Management of myocardial infarction and ischemia without obstructive coronary arteries: insights from a case series].
[Determination of myocardial risk on basis of the outcome of previous myocardial infarcts. Advantages of myocardial tomoscintigraphy using thallium with dipyridamole].
Association of Long Noncoding RNA Expression Signatures with Stress-Induced Myocardial Perfusion Defects.
[Myocardial no-reflow phenomenon: recent knowledges].
Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CT.
[Ten questions about myocardial infarction with non-obstructed coronary arteries].
[Predictive value of dipyridamole myocardial perfusion tomography on survival].